To further confirm the involvement of CDK9 on erythroid differentiation in CML cells, we detected the expression of surface antigens (CD71 and GPA) by flow cytometry analyses. This evidence concerns the gene CDK9 and chronic myelogenous leukemia, BCR-ABL1 positive.